<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p23" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_23{left:130px;bottom:1195px;letter-spacing:0.2px;}
#t2_23{left:804px;bottom:1195px;letter-spacing:0.13px;}
#t3_23{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_23{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_23{left:238px;bottom:1076px;letter-spacing:-0.01px;}
#t6_23{left:238px;bottom:1042px;letter-spacing:-0.01px;}
#t7_23{left:238px;bottom:1022px;letter-spacing:-0.01px;}
#t8_23{left:238px;bottom:1003px;letter-spacing:-0.01px;}
#t9_23{left:238px;bottom:983px;letter-spacing:-0.01px;}
#ta_23{left:238px;bottom:964px;letter-spacing:-0.01px;}
#tb_23{left:238px;bottom:944px;letter-spacing:-0.01px;}
#tc_23{left:238px;bottom:925px;letter-spacing:-0.01px;}
#td_23{left:238px;bottom:906px;letter-spacing:-0.01px;}
#te_23{left:238px;bottom:886px;letter-spacing:-0.01px;}
#tf_23{left:238px;bottom:867px;letter-spacing:-0.01px;}
#tg_23{left:238px;bottom:847px;letter-spacing:-0.01px;}
#th_23{left:238px;bottom:828px;letter-spacing:-0.01px;}
#ti_23{left:238px;bottom:808px;letter-spacing:-0.01px;}
#tj_23{left:238px;bottom:789px;letter-spacing:-0.01px;}
#tk_23{left:238px;bottom:696px;letter-spacing:-0.01px;}
#tl_23{left:238px;bottom:677px;letter-spacing:-0.01px;}
#tm_23{left:238px;bottom:657px;letter-spacing:-0.01px;}
#tn_23{left:238px;bottom:638px;letter-spacing:-0.01px;}
#to_23{left:238px;bottom:618px;letter-spacing:-0.01px;}
#tp_23{left:238px;bottom:599px;letter-spacing:-0.01px;}
#tq_23{left:238px;bottom:579px;letter-spacing:-0.01px;}
#tr_23{left:238px;bottom:560px;letter-spacing:-0.01px;}
#ts_23{left:238px;bottom:541px;letter-spacing:-0.01px;}
#tt_23{left:238px;bottom:521px;letter-spacing:-0.01px;}
#tu_23{left:238px;bottom:428px;letter-spacing:-0.01px;}
#tv_23{left:238px;bottom:409px;letter-spacing:-0.01px;}
#tw_23{left:238px;bottom:389px;letter-spacing:-0.01px;}
#tx_23{left:238px;bottom:370px;letter-spacing:-0.01px;}
#ty_23{left:238px;bottom:350px;letter-spacing:-0.01px;}
#tz_23{left:238px;bottom:331px;letter-spacing:-0.01px;}
#t10_23{left:238px;bottom:257px;letter-spacing:-0.01px;}
#t11_23{left:238px;bottom:238px;letter-spacing:-0.01px;}
#t12_23{left:238px;bottom:218px;letter-spacing:-0.01px;}
#t13_23{left:238px;bottom:199px;letter-spacing:-0.01px;}
#t14_23{left:238px;bottom:180px;letter-spacing:-0.01px;}
#t15_23{left:238px;bottom:161px;letter-spacing:0.11px;}
#t16_23{left:238px;bottom:141px;letter-spacing:0.1px;}
#t17_23{left:238px;bottom:122px;letter-spacing:0.1px;}
#t18_23{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_23{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_23{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_23{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts23" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg23Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg23" style="-webkit-user-select: none;"><object width="908" height="1286" data="23/23.svg" type="image/svg+xml" id="pdf23" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_23" class="t s0_23">3.2. Risk factors </span><span id="t2_23" class="t s1_23">23 </span>
<span id="t3_23" class="t s2_23">The influence of alcohol as a risk factor depends on the location. In particular, </span>
<span id="t4_23" class="t s2_23">supraglottic carcinomas arise from combined consumption, while glottic carcinomas are </span>
<span id="t5_23" class="t s2_23">more likely to be purely tobacco-associated [14]. </span>
<span id="t6_23" class="t s2_23">In addition to these two known noxious substances that can lead to laryngeal carcinoma, </span>
<span id="t7_23" class="t s2_23">there are also occupational causes. For example, laryngeal carcinoma caused by asbestos is </span>
<span id="t8_23" class="t s2_23">recognized as an occupational disease. Ionizing radiation, e.g. from uranium, has also been </span>
<span id="t9_23" class="t s2_23">recognized in the past as the cause of carcinoma in less than 100 cases under BK 2402. A </span>
<span id="ta_23" class="t s2_23">case-control study also described a 2.67-fold increased risk of laryngeal carcinoma after </span>
<span id="tb_23" class="t s2_23">occupational exposure to coal and tar products, which was adjusted for smoking and alcohol </span>
<span id="tc_23" class="t s2_23">[15]. Inhalation of aerosols containing sulfuric acid with an exposure level of at least 0.2 mg/ </span>
<span id="td_23" class="t s2_23">m3 and full-shift exposure for more than 5 years can lead to laryngeal carcinoma (BK No. </span>
<span id="te_23" class="t s2_23">1319) [16]. When exposed to sulfuric acid aerosols, the risk increases equally for smokers and </span>
<span id="tf_23" class="t s2_23">non-smokers [17]. Other occupational factors that have been highlighted in the literature, </span>
<span id="tg_23" class="t s2_23">such as cement dust, wood dust and emissions from volatile aromatics, have been shown to </span>
<span id="th_23" class="t s2_23">be less significant in meta-analyses [18]. Nevertheless, it can be postulated that fewer cases of </span>
<span id="ti_23" class="t s2_23">laryngeal cancer are observed in emission-free occupational environments than in </span>
<span id="tj_23" class="t s2_23">environments exposed to dust and emissions. </span>
<span id="tk_23" class="t s2_23">Infection with high-risk types of human papillomavirus (HPV), especially HPV16, is another risk </span>
<span id="tl_23" class="t s2_23">factor for laryngeal carcinoma, although it is significantly less significant than oropharyngeal </span>
<span id="tm_23" class="t s2_23">carcinoma. In rare cases, laryngeal carcinoma can also develop after long-term infection with </span>
<span id="tn_23" class="t s2_23">the low-risk types HPV6 or HPV11 [19, 20]. While earlier studies assumed a rate of 24% HPV- </span>
<span id="to_23" class="t s2_23">positive laryngeal carcinomas [21], current studies show much lower rates with 5.7% HPV- </span>
<span id="tp_23" class="t s2_23">positive laryngeal carcinomas [22]. However, the sole detection of HPV DNA in the carcinoma </span>
<span id="tq_23" class="t s2_23">is not sufficient to prove the causal role of HPV. Such proof can be achieved by additionally </span>
<span id="tr_23" class="t s2_23">detecting the mRNA of the viral oncoproteins E6 or E7. In contrast to oropharyngeal </span>
<span id="ts_23" class="t s2_23">carcinoma, the sole detection of p16(INK4A) protein expression is not a good surrogate </span>
<span id="tt_23" class="t s2_23">marker for an HPV-associated tumor in laryngeal carcinoma [23, 24]. </span>
<span id="tu_23" class="t s2_23">Under the premise of detecting viral DNA in combination with HPV E6 mRNA, only 3.1% of </span>
<span id="tv_23" class="t s2_23">laryngeal carcinomas were HPV-associated in a recent study [22]. In a meta-analysis that </span>
<span id="tw_23" class="t s2_23">included 2739 patients with laryngeal carcinomas, HPV DNA was detected in 22.1% of cases, </span>
<span id="tx_23" class="t s2_23">but E6/E7 mRNA was only detected in 8.6% of cases. Only in the latter cases can causal </span>
<span id="ty_23" class="t s2_23">carcinogenesis by HPV be assumed. In a study from Germany, a causal role of HPV16 in </span>
<span id="tz_23" class="t s2_23">laryngeal carcinoma could also only be demonstrated in &lt;5% of cases [25]. </span>
<span id="t10_23" class="t s2_23">However, the serological detection of antibodies against HPV16 is still associated with an </span>
<span id="t11_23" class="t s2_23">increase in the risk of laryngeal carcinoma by a factor of 2.4 [26]. Recently, it was shown that for </span>
<span id="t12_23" class="t s2_23">patients with antibodies against HPV16-E6, the risk of laryngeal carcinoma is increased by 4.18 </span>
<span id="t13_23" class="t s2_23">and for those with antibodies against HPV16-E6 &amp; E7, the risk is increased by 30.84. However, </span>
<span id="t14_23" class="t s2_23">for comparison, the risk of </span>
<span id="t15_23" class="t s1_23">The risk of oropharyngeal cancer is already 132-fold increased when HPV16-E6 antibodies are </span>
<span id="t16_23" class="t s1_23">detected. The risk of laryngeal cancer is also increased when antibodies against HPV6 are </span>
<span id="t17_23" class="t s1_23">detected (3.25-fold) [27]. </span>
<span id="t18_23" class="t s0_23">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
